[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@TOWiU2](/creator/twitter/TOWiU2)
"$SRPT will present at the 30th Annual Congress of the World Muscle Society (WMS) 2025 Congress taking place Oct. 7-11 2025 in Vienna Austria"  
[X Link](https://x.com/TOWiU2/status/1974787096608145743) [@TOWiU2](/creator/x/TOWiU2) 2025-10-05T10:41Z 1448 followers, 1982 engagements


"@PrivacySetting1 @BJLinvestment "the idea that it even remotely matters whether they do $XX or $XX or $XX million of revenue this quarter" It is part of the $169m that $HROW still has to deliver in 2025 to meet its own guidance which is important for mgmt's credibility. From this perspective it does matter"  
[X Link](https://x.com/TOWiU2/status/1977710211654648109) [@TOWiU2](/creator/x/TOWiU2) 2025-10-13T12:17Z 1448 followers, 2240 engagements


"@Biohazard3737 $HROW $ZLAB Week XX after Poll:"  
[X Link](https://x.com/TOWiU2/status/1979281811571085326) [@TOWiU2](/creator/x/TOWiU2) 2025-10-17T20:22Z 1448 followers, XXX engagements


"@ShortShitStocks Typical in my book would be Lonza BI or SBL. If form & fill Vetter or Siegfried. But Im not familiar with any "atypical-biotech-CMC""  
[X Link](https://x.com/TOWiU2/status/1973048477782253867) [@TOWiU2](/creator/x/TOWiU2) 2025-09-30T15:33Z 1448 followers, XX engagements


"@LTbioinvestor $VKTX $SRPT $CYTK $IDYA Week XX after Poll:"  
[X Link](https://x.com/TOWiU2/status/1979285242289496188) [@TOWiU2](/creator/x/TOWiU2) 2025-10-17T20:35Z 1448 followers, 1112 engagements


"$IONS $BIIB announced that the FDA issued a CRL for the Companys sNDA for the high dose regimen of nusinersen for the treatment of SMA. The FDA letter requested an update to the technical information be included in the CMC module of the sNDA"  
[X Link](https://x.com/TOWiU2/status/1970818434016395713) [@TOWiU2](/creator/x/TOWiU2) 2025-09-24T11:51Z 1449 followers, XXX engagements


"@Biohazard3737 $HROW $ZLAB Week XX after Poll:"  
[X Link](https://x.com/TOWiU2/status/1971667673508729233) [@TOWiU2](/creator/x/TOWiU2) 2025-09-26T20:06Z 1449 followers, XXX engagements


"$MLTX $KALA $IOBT ($LRMR) ($APLT)"  
[X Link](https://x.com/TOWiU2/status/1973476704405590037) [@TOWiU2](/creator/x/TOWiU2) 2025-10-01T19:54Z 1448 followers, 1336 engagements


"@Biohazard3737 $HROW $ZLAB Week XX after Poll:"  
[X Link](https://x.com/TOWiU2/status/1974219576847012083) [@TOWiU2](/creator/x/TOWiU2) 2025-10-03T21:06Z 1449 followers, XXX engagements


"POLL: Are your biggest concerns regarding $HROW the -California/Imprimis Acusation or rather - doubts about the $XXX million/2025 guidance - doubts about the $XXX million/4Q2027 guidance or the fact that - MELT-300 won't be on the market until 2028"  
[X Link](https://x.com/TOWiU2/status/1976173461820313778) [@TOWiU2](/creator/x/TOWiU2) 2025-10-09T06:30Z 1448 followers, 1332 engagements


"@Biohazard3737 $HROW $ZLAB Week XX after Poll:"  
[X Link](https://x.com/TOWiU2/status/1976767559211917530) [@TOWiU2](/creator/x/TOWiU2) 2025-10-10T21:51Z 1449 followers, XXX engagements


"@BehaviorFin $NTLA $QURE $SGMO $ADAP Week XX after Poll:"  
[X Link](https://x.com/TOWiU2/status/1976769019203207310) [@TOWiU2](/creator/x/TOWiU2) 2025-10-10T21:57Z 1449 followers, 1539 engagements


"@LTbioinvestor $VKTX $SRPT $CYTK $IDYA Week XX after Poll:"  
[X Link](https://x.com/TOWiU2/status/1976770673532968975) [@TOWiU2](/creator/x/TOWiU2) 2025-10-10T22:03Z 1450 followers, 1154 engagements


"@BehaviorFin $NTLA $QURE $SGMO $ADAP Week XX after Poll:"  
[X Link](https://x.com/TOWiU2/status/1979283261315539180) [@TOWiU2](/creator/x/TOWiU2) 2025-10-17T20:27Z 1448 followers, 1588 engagements


"$DCTH Prelim 3rd Q 2025 Financial Results Total CHEMOSAT & HEPZATO KIT rev of approx $20.5m HEPZATO KIT rev $19.2m CHEMOSAT rev $XXX Gross margins expected to be XX% Net income of $XXX million Pos adj EBITDA of $5.3m Pos op cashflow of $4.8m"  
[X Link](https://x.com/TOWiU2/status/1979652751346020559) [@TOWiU2](/creator/x/TOWiU2) 2025-10-18T20:56Z 1448 followers, 1234 engagements


"$DCTH 2025 Full Year Financial Guidance Total CHEMOSAT & HEPZATO KIT revenue of $83m to $85m reflecting an approximate XXX% increase in treatment volume over 2024 Quarterly gross margins between XX% to XX% Positive adjusted EBITDA and operating cashflow in each quarter of 2025"  
[X Link](https://x.com/TOWiU2/status/1979653195015278878) [@TOWiU2](/creator/x/TOWiU2) 2025-10-18T20:57Z 1448 followers, XXX engagements


"via @BioTechHealthX (1/N) "What sets $DCTH apart from traditional biotech companies is its drug-device hybrid model that creates durable competitive advantages and raises barriers to entry.""  
[X Link](https://x.com/TOWiU2/status/1979896779978985971) [@TOWiU2](/creator/x/TOWiU2) 2025-10-19T13:05Z 1448 followers, 1065 engagements


"(3/N) ". liver metastases typically lead X poor outcomes when treated w systemic checkpoint inhibitors alone due X the livers immunosuppressive microenvironment $DCTH s ability X enhance immunotherapy efficacy may position the company @ the forefront of a new treatment class""  
[X Link](https://x.com/TOWiU2/status/1979897735215010151) [@TOWiU2](/creator/x/TOWiU2) 2025-10-19T13:09Z 1448 followers, XXX engagements


"(4/4) "This could vastly expand its addressable market beyond uveal melanoma into much larger patient populations driving exponential revenue growth over the next decade." $DCTH"  
[X Link](https://x.com/TOWiU2/status/1979897915075178974) [@TOWiU2](/creator/x/TOWiU2) 2025-10-19T13:10Z 1448 followers, XXX engagements